Literature DB >> 27593156

An area-based study on intrapartum antibiotic prophylaxis for preventing group B streptococcus early-onset disease: advances and limitations.

Alberto Berardi1, Cecilia Rossi2, Maria Letizia Bacchi Reggiani3, Annalisa Bastelli4, Maria Grazia Capretti5, Claudio Chiossi6, Valentina Fiorini7, Lucia Gambini8, Sara Gavioli2, Marcello Lanari9, Luigi Memo10, Irene Papa11, Luana Pini12, Maria Vittoria Rizzo13, Andrea Zucchini14, Fabio Facchinetti15, Fabrizio Ferrari1.   

Abstract

INTRODUCTION: The prevalence of maternal group-B-streptococcus (GBS) colonization and risk factors (RFs) for neonatal early-onset disease (EOD) in Europe are poorly defined. Large-scale information concerning adherence to recommendations for preventing GBS-EOD are lacking.
MATERIALS AND METHODS: This was a 3-month retrospective area-based study including all regional deliveries  ≥35 weeks' gestation (in 2012). The sensitivity, specificity, positive and negative predictive values, odds ratio and receiver operating characteristic (ROC) curve for intrapartum antibiotic prophylaxis (IAP) among full-term and preterm deliveries and prolonged membrane rupture (PROM) were calculated.
RESULTS: Among 7133 women, 259 (3.6%) were preterm (35-36 weeks' gestation). Full-term women were 6874, and 876 (12.7%) had at least 1 RF. Most women (6495) had prenatal screening and 21.4% (1390) were GBS positive. IAP was given to 2369 (33.2%) women (preterm, n = 166; full term, n = 2203). Compared to full-term, preterm women were less likely to receive IAP when indicated (73.2% versus 90.3%, p < 0.01). Full-term women represented the largest area under the curve (AUC, 0.87). PROM showed the highest sensitivity (98.6%), but the lowest specificity (6.9%) and AUC (0.53).
CONCLUSIONS: Large-scale prenatal screening and IAP are feasible. Women delivering preterm are less likely to receive IAP when indicated. Most unnecessary antibiotics are given in cases of PROM.

Entities:  

Keywords:  Group B streptococcus; intrapartum antibiotic prophylaxis; newborn; prevention; risk factors; sepsis

Mesh:

Substances:

Year:  2016        PMID: 27593156     DOI: 10.1080/14767058.2016.1224832

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  8 in total

1.  Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies.

Authors:  Chryssoula Tzialla; Alberto Berardi; Claudio Farina; Pierangelo Clerici; Alessandro Borghesi; Elsa Viora; Paolo Scollo; Mauro Stronati
Journal:  Ital J Pediatr       Date:  2017-11-02       Impact factor: 2.638

2.  Vaccination With a Latch Peptide Provides Serotype-Independent Protection Against Group B Streptococcus Infection in Mice.

Authors:  Shun-Mei Lin; A-Yeung Jang; Yong Zhi; Shuang Gao; Sangyong Lim; Jae Hyang Lim; Joon Young Song; Paul M Sullam; Joon Haeng Rhee; Ho Seong Seo
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

3.  Secondary prevention of early-onset sepsis: a less invasive Italian approach for managing neonates at risk.

Authors:  Alberto Berardi; Chryssoula Tzialla; Laura Travan; Jenny Bua; Daniele Santori; Milena Azzalli; Caterina Spada; Laura Lucaccioni
Journal:  Ital J Pediatr       Date:  2018-06-28       Impact factor: 2.638

4.  Group B Streptococcus early-onset disease and observation of well-appearing newborns.

Authors:  Alberto Berardi; Caterina Spada; Maria Letizia Bacchi Reggiani; Roberta Creti; Lorenza Baroni; Maria Grazia Capretti; Matilde Ciccia; Valentina Fiorini; Lucia Gambini; Giancarlo Gargano; Irene Papa; Giancarlo Piccinini; Vittoria Rizzo; Fabrizio Sandri; Laura Lucaccioni
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

5.  Group B streptococcal screening, intrapartum antibiotic prophylaxis, and neonatal early-onset infection rates in an Australian local health district: 2006-2016.

Authors:  Kathryn Braye; Maralyn Foureur; Koert de Waal; Mark Jones; Elise Putt; John Ferguson
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

6.  Adherence to screening and management guidelines of maternal Group B Streptococcus colonization in pregnancy.

Authors:  Sabine Pangerl; Deborah Sundin; Sadie Geraghty
Journal:  J Adv Nurs       Date:  2022-04-15       Impact factor: 3.057

7.  Epidemiology and complications of late-onset sepsis: an Italian area-based study.

Authors:  Alberto Berardi; Francesca Sforza; Lorenza Baroni; Caterina Spada; Simone Ambretti; Giacomo Biasucci; Serenella Bolognesi; Mariagrazia Capretti; Edoardo Carretto; Matilde Ciccia; Marcello Lanari; Maria Federica Pedna; Vittoria Rizzo; Claudia Venturelli; Crisoula Tzialla; Laura Lucaccioni; Maria Letizia Bacchi Reggiani
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

8.  Invasive Group B Streptococcal Disease in Neonates and Infants, Italy, Years 2015-2019.

Authors:  Roberta Creti; Monica Imperi; Alberto Berardi; Erika Lindh; Giovanna Alfarone; Marco Pataracchia; Simona Recchia
Journal:  Microorganisms       Date:  2021-12-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.